Pharmacy Times May 10, 2022
Joel Wayment, vice president of operations for 3PL Services at Cardinal Health, discusses how the pharmaceutical supply chain currently manages the transport of CAR T products to sites of administration.
Pharmacy Times interviewed Joel Wayment, vice president of operations for 3PL Services at Cardinal Health, on some of the logistical challenges in the transport of chimeric antigen receptor (CAR) T-cell therapy products.
Question: How does the pharmaceutical supply chain currently manage the transport of CAR T products to sites of administration?
Joel Wayment: Yeah, these products are incredibly sensitive, and so it takes a lot of unique solutions to make sure that you’re transporting these products in the correct fashion. You can’t utilize just your standard commercial carrier to move...
Today's Sponsors
Today's Sponsor